Back
Akebia Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
AKBA
Akebia Therapeutics
Last Price:
1.87
Seasonality Move:
46.76%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.84 | Buy |
| 20-day SMA: | 1.83 | Buy |
| 50-day SMA: | 1.55 | Buy |
| 200-day SMA: | 1.41 | Buy |
| 8-day EMA: | 1.84 | Buy |
| 20-day EMA: | 1.79 | Buy |
| 50-day EMA: | 1.63 | Buy |
| 200-day EMA: | 1.41 | Buy |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 61.05 | Buy |
| Chaikin Money Flow: | 1174085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.62 - 1.92) | Buy |
| Bollinger Bands (100): | (1.22 - 1.68) | Buy |
Akebia Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.88 while AKBA 8-day simple moving average is 1.84, which is a Buy signal.
- The stock price of AKBA is 1.88 while Akebia Therapeutics 20-day SMA is 1.83, which makes it a Buy.
- Akebia Therapeutics 50-day simple moving average is 1.55 while AKBA share price is 1.88, making it a Buy technically.
- AKBA stock price is 1.88 and Akebia Therapeutics 200-day simple moving average is 1.41, creating a Buy signal.
AKBA Technical Analysis vs Fundamental Analysis
Buy
63
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a Buy
The current Akebia Therapeutics [AKBA] share price is $1.88. The Score for AKBA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
410.18M
Price in USD:
1.88
Share Volume:
2M
Akebia Therapeutics 52-Week Range
52-Week High:
2.48
52-Week Low:
0.80
Buy
63
Akebia Therapeutics (AKBA)
is a Buy
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?
The Akebia Therapeutics stock price is 1.88 USD today. -
Will AKBA stock go up or go down?
Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akebia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is not overvalued.
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.88 while AKBA 8-day exponential moving average is 1.84, which is a Buy signal.
- The stock price of AKBA is 1.88 while Akebia Therapeutics 20-day EMA is 1.79, which makes it a Buy.
- Akebia Therapeutics 50-day exponential moving average is 1.63 while AKBA share price is 1.88, making it a Buy technically.
- AKBA stock price is 1.88 and Akebia Therapeutics 200-day simple moving average is 1.41, creating a Buy signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
- AKBA Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Akebia Therapeutics is a Buy
- Akebia Therapeutics Relative Strength Index (RSI) is 61.05, which suggest Akebia Therapeutics is overbought
- The Bollinger Bands (25) for Akebia Therapeutics is (1.62 - 1.92), which suggest Akebia Therapeutics is a Buy
- The Bollinger Bands (100) for Akebia Therapeutics is (1.22 - 1.68), which suggest Akebia Therapeutics is a Buy
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.